Safety Considerations and Side Effects BPC-157 demonstrates a remarkably favorable safety profile across available research and extensive anecdotal use
That translates into reduced snacking and reduced bingeing
In addition, pathway analysis has shown that DNA replication pathway was significantly modified, and differential gene analysis revealed that colony stimulating factor 3 (CSF3), plasminogen activator, urokinase (PLAU), ubiquitin like with PHD and ring finger domains 1 (UHRF1), FOS like 1, AP-1 transcription factor subunit (FOSL1), IL1B, dual specificity phosphatase 6 (DUSP6), minichromosome maintenance complex component (MCM)2, cyclin D1 (CCND1), Wnt family member 7B (WNT7B), MCM5, MCL1 apoptosis regulator (MCL1), SH2B adaptor protein 3 (SH2B3), MCM3, heterogeneous nuclear ribonucleoprotein M (HNRNPM), and paralemmin 2 and A-kinase anchoring protein 2 fusion (PALM2AKAP2) were upregulated and activating transcription factor 4 (ATF4), farnesyl-diphosphate farnesyltransferase 1 (FDFT1), adenylate cyclase 8 (ADCY8), cytochrome P450 family 1 subfamily B member 1 (CYP1B1), epiregulin (EREG), family with sequence similarity 114 member A1 (FAM114A1), eukaryotic translation initiation factor 4A2 (EIF4A2), aldo-keto reductase family 1 member B (AKR1B1), mitogen-activated protein kinase 1 interacting protein 1 like (C14orf132), collagen type I alpha 2 chain (COL1A2), cyclin dependent kinase inhibitor 1 A (CDKN1A), aspartate beta-hydroxylase (ASPH), DEPP autophagy regulator 1 (DEPP1), aldo-keto reductase family 1 member C1 (AKR1C1), and DNA damage inducible transcript 4 (DDIT4) were downregulated in treated SPF mice when compared to the untreated mice [253]
Carrying excess weight affects far more than cardiovascular health or blood sugar levels
10.1007/s12011-025-04666-2 182 ShiG
